Company · CIK 0000949858 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
ACHIEVE LIFE SCIENCES, INC. · ACHV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 SForm 4 → | Aug 21, 4:30 pm EDT | Richard Alistair StewartDirector | 20,626 | $8.49 | $175,177 | 208,249 | −9.01% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 AForm 4 → | Jul 29, 5:26 pm EDT | Thomas SelligDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:24 pm EDT | Christopher Nathan MartinDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:22 pm EDT | Aaron RoystonDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:21 pm EDT | Reid Alexander WaldmanDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:20 pm EDT | Richard Alistair StewartDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:19 pm EDT | Jeffrey S FarrowDirector | 41,700 | — | — | 16,700 | — | |
| Jul 27, 2026 AForm 4 → | Jul 29, 5:17 pm EDT | Nancy R. PhelanDirector | 41,700 | — | — | 16,700 | — |